Replimune REPL
NASDAQ REPL
$13.00 +0.44 (+3.50%)
At close: Sep 29, 2026 · 4:00 PM EDT

Replimune (REPL) Total Liabilities (2018 - 2026)

Updated

Replimune (REPL) recorded Total Liabilities of $146.8 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 10.6% from $132.79 million a year earlier but down 11.7% from the prior quarter.

Analysis

Replimune (REPL) Total Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Replimune reported Total Liabilities of $166.23 million, up 22.7% from FY2025.

  • Annual Total Liabilities has increased for five straight fiscal years, with a five-year compound annual growth rate of 30.2% (FY2021 to FY2026).
  • Across earlier fiscal years, Total Liabilities came in at $135.49 million in FY2025 (+19.7%), $113.21 million in FY2024 (+24.0%), $91.3 million in FY2023 (+82.7%) and $49.96 million in FY2022 (+12.6%).
  • Quarterly Total Liabilities has ranged from $46.05 million in fiscal Q2 2022 to $166.23 million in fiscal Q4 2026 over the past five years.
  • On a year-over-year basis, Total Liabilities has increased for 19 consecutive quarters, with growth averaging 14.2% over the last eight quarters.
  • Peak year-over-year performance for Total Liabilities in the last five years was growth of 86.9% in fiscal Q2 2024, against a decline of 12.9% in fiscal Q2 2022 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $166.23 million (Q4 2026), $123.05 million (Q3 2026) and $126.11 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Replimune 1.05 Bn 1.05 Bn - 146.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 146.80 Mn
Mar 31, 2026 166.23 Mn
Dec 31, 2025 123.05 Mn
Sep 30, 2025 126.11 Mn
Jun 30, 2025 132.79 Mn
Mar 31, 2025 135.49 Mn
Dec 31, 2024 121.25 Mn
Sep 30, 2024 116.74 Mn
Jun 30, 2024 108.51 Mn
Mar 31, 2024 113.21 Mn
Dec 31, 2023 111.39 Mn
Sep 30, 2023 97.23 Mn
Jun 30, 2023 89.86 Mn
Mar 31, 2023 91.30 Mn
Dec 31, 2022 83.21 Mn
Sep 30, 2022 52.02 Mn
Jun 30, 2022 49.17 Mn
Mar 31, 2022 49.96 Mn
Dec 31, 2021 47.77 Mn
Sep 30, 2021 46.05 Mn
API Access

Replimune Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=REPL&period=max&api_key=YOUR_API_KEY